Improving outcomes and quality of life for patients with transfusion-dependent β-thalassemia: recommendations for best clinical practice and the use of novel treatment strategies-Reference-Cited by-同舟云学术

Improving outcomes and quality of life for patients with transfusion-dependent β-thalassemia: recommendations for best clinical practice and the use of novel treatment strategies

Published:2021-09-15 Issue:10 Volume:14 Page:897-909
ISSN:1747-4086
Container-title:Expert Review of Hematology
language:en
Short-container-title:Expert Review of Hematology

Author:

Taher Ali T.¹^ORCID,Bou-Fakhredin Rayan¹^ORCID,Kattamis Antonis²^ORCID,Viprakasit Vip³,Cappellini Maria Domenica⁴^ORCID

Affiliation:

1. Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon

2. First Department of Pediatrics, National and Kapodistrian University of Athens, Athens, Greece

3. Siriraj Center of Excellence on Advanced Gene and Cellular Therapy (Si-COE-AGCT) & Department of Pediatrics, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand

4. Fondazione IRCCS Ca’ Granda Policlinico Hospital, University of Milan, Milan, Italy

Funder

writing and editorial support funded by Bristol Myers Squibb

Publisher

Informa UK Limited

Subject

Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/17474086.2021.1977116

Reference108 articles.

1. β-Thalassemia

2. Global epidemiology of haemoglobin disorders and derived service indicators